Daily Archives: 2012/04/05
Oral Fluoroquinolones Slightly Raise Risk Of Retinal Detachment
According to a study published in the April 4 issue of JAMA , individuals have an increased, although overall small risk of developing a serious eye condition called retinal detachment when taking oral fluoroquinolones. The study included nearly 1 million patients who had visited an ophthalmologist...
Inflammatory ocular adverse events with use of oral bisphosphonates: retrospective cohort study
Source: CMAJ
Area: News
Following reports of inflammatory ocular adverse events, mainly uveitis and scleritis, among patients on oral bisphosphonates, this retrospective cohort study examined the risk of these adverse events in residents of British Columbia who had visited an ophthalmologist from 2000 to 2007. The cohort comprised 934,147 people, including 10,827 first-time users of bisphosphonates and 923,320 non-users, who were followed to the first inflammatory ocular adverse event, death, termination of insurance or the end of the study period. An inflammatory ocular adverse event was defined as scleritis or uveitis. The following findings were reported: . The incidence rate among first-time users was 29/10,000 person-years for uveitis and 63/10,000 person-years for scleritis. . The incidence among people who did not use oral bisphosphonates was 20/10,000 person-years for uveitis and 36/10,000 for scleritis (number needed to harm: 1100 and ...
Area: News
Following reports of inflammatory ocular adverse events, mainly uveitis and scleritis, among patients on oral bisphosphonates, this retrospective cohort study examined the risk of these adverse events in residents of British Columbia who had visited an ophthalmologist from 2000 to 2007. The cohort comprised 934,147 people, including 10,827 first-time users of bisphosphonates and 923,320 non-users, who were followed to the first inflammatory ocular adverse event, death, termination of insurance or the end of the study period. An inflammatory ocular adverse event was defined as scleritis or uveitis. The following findings were reported: . The incidence rate among first-time users was 29/10,000 person-years for uveitis and 63/10,000 person-years for scleritis. . The incidence among people who did not use oral bisphosphonates was 20/10,000 person-years for uveitis and 36/10,000 for scleritis (number needed to harm: 1100 and ...
Monash Vision Group Bionic Eye microchip
2014 may well end up being be the year of the bionic eye. At least that’s the goal of engineers from the Monash Vision Group (MVG) of Monash University in Australia. They’ve recently had extremely positive early laboratory results for a new microchip that will power a bionic eye, and are on track for having one ready for patient testin (Read more...)
Increased Complications of DSEK After Tube Shunts
The unique challenges of Descemet stripping automated endothelial keratoplasty in patients with previous glaucoma drainage device insertion are highlighted by this case series.
Medscape Ophthalmology
Medscape Ophthalmology
Subscribe
